CDK 4/6 inhibitors effective at treating breast cancer across all age groups (1)

25 Nov 2019


A combination of CDK 4/6 and aromatase inhibitors appear to be effective at treating breast cancer in women of all ages, according to a study published in the Journal of Clinical Oncology.

Healio


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story